Genesee Valley Trust Company Trimmed Northrup Grumman Corp. (NOC) Holding; National Planning Cut Seattle Genetics (SGEN) Holding By $894,240

Genesee Valley Trust Company decreased Northrup Grumman Corp. (NOC) stake by 36.44% reported in 2017Q3 SEC filing. Genesee Valley Trust Company sold 1,429 shares as Northrup Grumman Corp. (NOC)’s stock rose 2.59%. The Genesee Valley Trust Company holds 2,493 shares with $717,000 value, down from 3,922 last quarter. Northrup Grumman Corp. now has $61.98 billion valuation. The stock decreased 0.25% or $0.91 during the last trading session, reaching $356. About 957,892 shares traded or 2.14% up from the average. Northrop Grumman Corporation (NYSE:NOC) has risen 18.39% since February 18, 2017 and is uptrending. It has outperformed by 1.69% the S&P500.

National Planning Corp decreased Seattle Genetics Inc (SGEN) stake by 14.92% reported in 2017Q3 SEC filing. National Planning Corp sold 16,560 shares as Seattle Genetics Inc (SGEN)’s stock rose 1.68%. The National Planning Corp holds 94,430 shares with $5.14 million value, down from 110,990 last quarter. Seattle Genetics Inc now has $8.46B valuation. The stock decreased 0.67% or $0.37 during the last trading session, reaching $54.48. About 965,192 shares traded. Seattle Genetics, Inc. (NASDAQ:SGEN) has risen 75.68% since February 18, 2017 and is uptrending. It has outperformed by 58.98% the S&P500.

National Planning Corp increased Vanguard World Fd (MGV) stake by 5,280 shares to 14,830 valued at $1.07M in 2017Q3. It also upped Ishares Tr (IXN) stake by 3,217 shares and now owns 17,950 shares. Vanguard Bd Index Fd Inc (BIV) was raised too.

Since August 24, 2017, it had 1 buying transaction, and 16 insider sales for $189.84 million activity. Another trade for 8,502 shares valued at $407,199 was made by DRACHMAN JONATHAN G on Monday, August 28. HIMES VAUGHN B had sold 10,000 shares worth $532,190 on Friday, September 8. SIEGALL CLAY B sold 18,832 shares worth $973,873. Cline Darren S sold 7,569 shares worth $397,466. DOBMEIER ERIC sold 25,000 shares worth $1.31 million. $200.00 million worth of stock was bought by BAKER BROS. ADVISORS LP on Thursday, February 1. $501,176 worth of Seattle Genetics, Inc. (NASDAQ:SGEN) shares were sold by SIMPSON TODD E.

Investors sentiment decreased to 0.78 in 2017 Q3. Its down 0.52, from 1.3 in 2017Q2. It fall, as 51 investors sold SGEN shares while 74 reduced holdings. 29 funds opened positions while 69 raised stakes. 140.23 million shares or 2.00% more from 137.48 million shares in 2017Q2 were reported. Howe & Rusling owns 40 shares for 0% of their portfolio. California State Teachers Retirement Sys holds 157,451 shares or 0.02% of its portfolio. Campbell Adviser Lc owns 0.24% invested in Seattle Genetics, Inc. (NASDAQ:SGEN) for 5,356 shares. Raymond James Finance Advsrs Inc holds 4,654 shares. Vantage Investment Advisors Ltd Liability Company holds 0.01% in Seattle Genetics, Inc. (NASDAQ:SGEN) or 600 shares. Trexquant Invest LP reported 4,159 shares. Amalgamated Natl Bank stated it has 0.03% of its portfolio in Seattle Genetics, Inc. (NASDAQ:SGEN). Cornerstone Incorporated holds 150 shares. Weiss Multi, a Alabama-based fund reported 15,000 shares. Atria Investments Lc holds 0.02% or 5,714 shares. Redmile Group Incorporated Lc has 4.95% invested in Seattle Genetics, Inc. (NASDAQ:SGEN) for 1.84M shares. 18,684 were reported by State Of Wisconsin Investment Board. Lagoda Management Limited Partnership accumulated 306,694 shares or 6.03% of the stock. Bnp Paribas Arbitrage reported 0% of its portfolio in Seattle Genetics, Inc. (NASDAQ:SGEN). 26,874 are held by Fjarde Ap.

Among 18 analysts covering Seattle Genetics (NASDAQ:SGEN), 9 have Buy rating, 0 Sell and 9 Hold. Therefore 50% are positive. Seattle Genetics has $77.0 highest and $4300 lowest target. $63’s average target is 15.64% above currents $54.48 stock price. Seattle Genetics had 64 analyst reports since July 31, 2015 according to SRatingsIntel. On Monday, September 14 the stock rating was maintained by RBC Capital Markets with “Outperform”. The firm has “Hold” rating by Oppenheimer given on Wednesday, November 8. Cantor Fitzgerald maintained it with “Hold” rating and $4300 target in Monday, June 26 report. The company was maintained on Monday, June 26 by Cowen & Co. The firm earned “Hold” rating on Tuesday, August 29 by Cantor Fitzgerald. The firm has “Hold” rating given on Thursday, June 15 by Oppenheimer. The firm earned “Equal-Weight” rating on Monday, October 16 by Barclays Capital. H.C. Wainwright maintained Seattle Genetics, Inc. (NASDAQ:SGEN) on Monday, June 19 with “Buy” rating. The stock of Seattle Genetics, Inc. (NASDAQ:SGEN) has “Hold” rating given on Thursday, July 27 by Cowen & Co. Oppenheimer maintained the shares of SGEN in report on Wednesday, August 16 with “Hold” rating.

Among 18 analysts covering Northrop Grumman (NYSE:NOC), 12 have Buy rating, 0 Sell and 6 Hold. Therefore 67% are positive. Northrop Grumman has $394.0 highest and $185 lowest target. $313.27’s average target is -12.00% below currents $356 stock price. Northrop Grumman had 57 analyst reports since July 30, 2015 according to SRatingsIntel. RBC Capital Markets initiated Northrop Grumman Corporation (NYSE:NOC) rating on Thursday, January 12. RBC Capital Markets has “Outperform” rating and $268 target. The company was maintained on Friday, September 29 by RBC Capital Markets. The rating was maintained by Jefferies on Monday, August 28 with “Hold”. On Thursday, May 19 the stock rating was downgraded by RBC Capital Markets to “Sector Perform”. Jefferies upgraded Northrop Grumman Corporation (NYSE:NOC) on Wednesday, February 14 to “Buy” rating. RBC Capital Markets maintained it with “Buy” rating and $389.0 target in Tuesday, January 23 report. The rating was maintained by Stifel Nicolaus with “Hold” on Monday, January 8. The firm has “Hold” rating given on Monday, July 24 by Jefferies. The company was maintained on Monday, July 17 by Cowen & Co. As per Thursday, October 26, the company rating was maintained by RBC Capital Markets.

Since October 27, 2017, it had 0 insider purchases, and 1 sale for $1.88 million activity. 6,311 shares were sold by ASHWORTH SID, worth $1.88M on Friday, October 27.

Genesee Valley Trust Company increased Adobe Sys Inc. (NASDAQ:ADBE) stake by 3,694 shares to 20,078 valued at $3.00M in 2017Q3. It also upped United Technologies Corp (NYSE:UTX) stake by 4,198 shares and now owns 8,534 shares. Fpa New Income (FPNIX) was raised too.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: